Pulmonary Arterial Hypertension and the Sex Hormone Paradox Andrew FoderaroCorey E. Ventetuolo Pulmonary Hypertension (J Klinger, Section Editor) 10 November 2016 Article: 84
Effects of Aspirin on Endothelial Function and Hypertension Mikhail S. DzeshkaAlena ShantsilaGregory Y. H. Lip Antihypertensive Agents: Mechanisms of Drug Action (ME Ernst, Section Editor) Open access 27 October 2016 Article: 83
A Clinical Perspective: Contribution of Dysfunctional Perivascular Adipose Tissue (PVAT) to Cardiovascular Risk Xiaoming LianMaik Gollasch Hypertension and Obesity (E Reisin, Section Editor) 27 October 2016 Article: 82
Should All Patients with Resistant Hypertension Receive Spironolactone? Ján RosaTomáš ZelinkaJiří Widimský Jr Resistant Hypertension (E Pimenta, Section Editor) 27 October 2016 Article: 81
White Coat Hypertension: to Treat or Not to Treat? Cesare CuspidiCarla SalaGiuseppe Mancia Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor) 27 October 2016 Article: 80
Endoluminal Treatments for Obesity and Related Hypertension: Updates, Review, and Clinical Perspective Courtney CrippsMitchell Roslin Hypertension and Obesity (E Reisin, Section Editor) 26 October 2016 Article: 79
Isolated Systolic Hypertension in Young and Middle-Aged Adults Yuichiro YanoDonald M. Lloyd-Jones Blood Pressure Monitoring and Management (J Cockcroft, Section Editor) 13 October 2016 Article: 78
Hypertension in Athletes and Active Populations Kevin T. SchleichM. Kyle SmootMichael E. Ernst Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor) 13 October 2016 Article: 77